stride study semaglutide Sex Differences in Effectiveness of in Patients With Peripheral Artery Disease: The Trial ACC 25 Late-Breaking Discussion: STRIDE:

The Science Behind Medical Semaglutide Weight Loss Semaglutides weight loss effects are attributed to its ability to reduce appetite and calorie intake

Extracellular fluid viscosity enhances cell migration and cancer dissemination

Planning for dose holds and breaks Sometimes you need to pause your medication

Retatrutide (research code LY-3437943) is a synthetic 39-amino-acid peptide developed by Eli Lilly as a novel triple agonist of the glucagon-like peptide-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIP-R), and glucagon receptor (GCG-R)

Sources and Further Reading Reta Support links to trusted sources when discussing health-adjacent topics

The glucagon-like peptide-1 analogue liraglutide reduces seizures susceptibility, cognition dysfunction and neuronal apoptosis in a mouse model of Dravet syndrome